Section : Patient care
The Psychotic Disorders Program at the Douglas Institute provides services to adults aged 18 to 65 with schizophrenia or other forms of psychoses, with the exception of the Prevention and Early Intervention Program for Psychoses (PEPP-Montréal), which is designed for people aged 14 to 30.
Section : Patient care
The Geriatric Psychiatry Program at the Douglas Institute provides services to clients aged 65 and older and to adults younger than 65 with a geriatric profile. The program covers psychiatric diagnoses such as: mood disorders anxiety di
Section : Patient care
The Severe Disruptive Disorders Program offers a range of superspecialized services for children aged 6 to 12 years with behaviour problems with or without an attention deficit disorder / hyperactivity disorder (ADHD).
Section : Mental Health Info
Mental Illness: The Facts and the Fiction The theme of the 2009 Session of Mini-Psych is Mental Illness: The Facts and the Fiction. Each of the 6 classes given by an expert from the Douglas Institute is exploring the
Section : The Douglas
Douglas Hospital was founded in 1881 by Alfred Perry and a group of Protestant clergy and Montréal citizens.
Section : Mental Health Info
Cognitive remediation is a computer-assisted therapy that promotes the stimulation of cognitive skills necessary for everyday life. Many studies have shown this therapy to have a measurable impact on cognitive deficits related to dementia, making it an invaluable intervention tool in the treatment of Alzheimer's disease.
Section : Research
Mallar Chakravarty is interested in the anatomy of the brain and how it changes through development, aging, and in illness.
Section : Research
Brigitte L. Kieffer, PhD, is the new Scientific Director of the Douglas Institute Research Centre
Section : The Douglas
As the professional chief of psychology , Margaret Peggy O'Byrne is responsible for evaluating the quality of professional acts of psychologists.
Section : Research
John Breitner, MD, has devoted his career to investigating factors that modify an individual’s risk of developing Alzheimer's Disease.